Pharmacological perspectives and phytochemical reservoir of Withania somnifera: A review
##semicolon##
https://doi.org/10.52984/ijomrc1102##semicolon##
Withania somnifera##common.commaListSeparator## Withanolides##common.commaListSeparator## Pharmacological activity##common.commaListSeparator## Anti-diabetic##common.commaListSeparator## Anti-tumourसार
Plants have always been an indispensable part of human life since the beginning of human civilisation. Withania somnifera (L.) DUNAL, popularly known as Wintercherry or Indian Ginseng, is widely considered as Ashwagandha. In Ayurveda, it is classified as a Rasayana (rejuvenation) and projected to promote mental and physical health, rejuvenate the body in debilitated conditions and increase longevity. Due to its beneficial chemical constituents, the herb possesses a broad spectrum of biological activities and is used to treat a variety of diseases affecting human health. These include cardioprotective, anti-cancer, immunomodulatory, neuroprotective, antimicrobial, anti-stress, anti-diabetic and anti-inflammatory activities. The present review discusses the pharmacological importance of Withania somnifera and its important constituents.
##submission.citations##
[1] Woods, D., Epistemic Things in Charles and Ray Eames’s Powers of Ten. In Scale in Literature and Culture, Springer: 2017; pp 61-92.
[2] Hayat, S.; Ali, B.; Ahmad, A., Salicylic acid: biosynthesis, metabolism and physiological role in plants. In Salicylic acid: A plant hormone, Springer: 2007; pp 1-14.
[3] Koutsospyros, A. D.; Koutsospyros, D. A.; Strigul, N.; Braida, W.; Christodoulatos, C., Tungsten: Environmental pollution and health effects. In Encyclopedia of environmental health, Elsevier: 2019; pp 161-169.
[4] Kong, J.-M.; Goh, N.-K.; Chia, L.-S.; Chia, T.-F., Recent advances in traditional plant drugs and orchids. Acta Pharmacologica Sinica 2003, 24 (1), 7-21.
[5] Petrovska, B. B., Historical review of medicinal plants’ usage. Pharmacognosy reviews 2012, 6 (11), 1.
[6] Sangwan, N. S.; Tripathi, S.; Srivastava, Y.; Mishra, B.; Pandey, N., Phytochemical genomics of Ashwagandha. In Science of Ashwagandha: Preventive and Therapeutic Potentials, Springer: 2017; pp 3-36
[7] Rates, S. M. K., Plants as source of drugs. Toxicon 2001, 39 (5), 603-613.
[8] Mukherjee, P. K.; Harwansh, R. K.; Bahadur, S.; Banerjee, S.; Kar, A.; Chanda, J.; Biswas, S.; Ahmmed, S. M.; Katiyar, C., Development of Ayurveda–tradition to trend. Journal of ethnopharmacology 2017, 197, 10-24.
[9] Patwardhan, B.; Warude, D.; Pushpangadan, P.; Bhatt, N., Ayurveda and traditional Chinese medicine: a comparative overview. Evidence-Based Complementary and Alternative Medicine 2005, 2.
[10] Tiwari, S., Plants: A rich source of herbal medicine. Journal of natural products 2008, 1 (0), 27-35.
[11] Yesilada, E., Past and future contributions to traditional medicine in the health care system of the Middle-East. Journal of Ethnopharmacology 2005, 100 (1-2), 135-137.
[12] Ackerknecht, E. H.; Haushofer, L., A short history of medicine. JHU Press: 2016.
[13] Rai, A.; Rai, A. C., Microbial endophytes and their intellectual property rights. In Microbial Endophytes, Elsevier: 2020; pp 349-387.
[14] Dutfield, G.; Suthersanen, U., Traditional Knowledge and Genetic Resources: Observing Legal Protection through the Lens of Historical Geography and Human Rights. Washburn LJ 2019, 58, 399.
[15] Alamgir, A., Secondary Metabolites: Secondary Metabolic Products Consisting of C and H; C, H, and O; N, S, and P Elements; and O/N Heterocycles. In Therapeutic Use of Medicinal Plants and their Extracts: Volume 2, Springer: 2018; pp 165-309
[16] Fischer, R.; Stoger, E.; Schillberg, S.; Christou, P.; Twyman, R. M., Plant-based production of biopharmaceuticals. Current opinion in plant biology 2004, 7 (2), 152-158.
[17] Twyman, R. M.; Stoger, E.; Schillberg, S.; Christou, P.; Fischer, R., Molecular farming in plants: host systems and expression technology. TRENDS in Biotechnology 2003, 21 (12), 570-578.
[18] Verpoorte, R., Exploration of nature's chemodiversity: the role of secondary metabolites as leads in drug development. Drug Discovery Today 1998, 3 (5), 232-238.
[19] Tripathi, S.; Srivastava, Y.; Sangwan, R. S.; Sangwan, N. S., In silico mining and functional analysis of AP2/ERF gene in Withania somnifera. Scientific reports 2020, 10 (1), 1-1
[20] Tripathi, S.; Sangwan, R. S.; Narnoliya, L. K.; Srivastava, Y.; Mishra, B.; Sangwan, N. S., Transcription factor repertoire in Ashwagandha (Withania somnifera) through analytics of transcriptomic resources: Insights into regulation of development and withanolide metabolism. Scientific reports 2017, 7 (1), 1-17.
[21] Edreva, A.; Velikova, V.; Tsonev, T.; Dagnon, S.; Gürel, A.; Aktaş, L.; Gesheva, E., Stress-protective role of secondary metabolites: diversity of functions and mechanisms. Gen Appl Plant Physiol 2008, 34 (1-2), 67-78.
[22] Srivastava, Y.; Sangwan, N. S., Chapter 17 - Improving medicinal crops through phytochemical perspective: Withania somnifera (Ashwagandha). In Advancement in Crop Improvement Techniques, Tuteja, N.; Tuteja, R.; Passricha, N.; Saifi, S. K., Eds. Woodhead Publishing: 2020; pp 275-295.
[23] Aharoni, A.; Galili, G., Metabolic engineering of the plant primary–secondary metabolism interface. Current opinion in biotechnology 2011, 22 (2), 239-244.
[24] Pichersky, E.; Gang, D. R., Genetics and biochemistry of secondary metabolites in plants: an evolutionary perspective. Trends in plant science 2000, 5 (10), 439-445.
[25] Phillipson, J. D., Phytochemistry and medicinal plants. Phytochemistry 2001, 56 (3), 237-243.
[26] Bourgaud, F.; Gravot, A.; Milesi, S.; Gontier, E., Production of plant secondary metabolites: a historical perspective. Plant science 2001, 161 (5), 839-851.
[27] Achar, G. P. K.; Prabhakar, B.; Rao, S.; George, T.; Abraham, S.; Sequeira, N.; Baliga, M. S., Scientific Validation of the Usefulness of Withania somnifera Dunal in the Prevention and Treatment of Cancer. In Anticancer Plants: Properties and Application, Springer: 2018; pp 285-301.
[28] Gurib-Fakim, A., Medicinal plants: traditions of yesterday and drugs of tomorrow. Molecular aspects of Medicine 2006, 27 (1), 1-93.
[29] Almoulah, N. F. Phytochemical study and biological evaluation of five plants belonging to the family Solanaceae. Université de Lorraine, 2017.
[30] Kumar, A.; Kaul, M.; Bhan, M.; Khanna, P. K.; Suri, K., Morphological and chemical variation in 25 collections of the Indian medicinal plant, Withania somnifera (L.) Dunal (Solanaceae). Genetic Resources and Crop Evolution 2007, 54 (3), 655-660.
[31] Rajeswara Rao, B., Opportunities and challenges in the cultivation of Ashwagandha {Withania somnifera (L.) Du-nal}. Journal of Pharmacognosy, ISSN 2012.
[32] Singh, N.; Bhalla, M.; de Jager, P.; Gilca, M., An overview on ashwagandha: A Rasayana (Rejuvenator) of Ayurveda. African Journal of Traditional, Complementary and Alternative Medicines 2011, 8 (5S).
[33] Mirjalili, M. H.; Moyano, E.; Bonfill, M.; Cusido, R. M.; Palazón, J., Steroidal lactones from Withania somnifera, an ancient plant for novel medicine. Molecules 2009, 14 (7), 2373-2393.
[34] Wasnik, N. G.; Muthusamy, M.; Chellappan, S.; Vaidhyanathan, V.; Pulla, R.; Senthil, K.; Yang, D. C., Establishment of in vitro root cultures and analysis of secondary metabolites in Indian Ginseng-Withania somnifera. Korean J Plant Res 2009, 22, 584-91.
[35] Khan, J.; Srivastava, P.; Singh, S., Sensitive detection of a phytoplasma associated with little leaf symptoms in Withania somnifera. European journal of plant pathology 2006, 115 (4), 401-408.
[36] Martín-Herrera, D.; Abdala, S.; Benjumea, D.; Pérez-Paz, P., Diuretic activity of Withania aristata: An endemic Canary Island species. Journal of ethnopharmacology 2007, 113 (3), 487-491.
[37] Mir, B. A.; Khazir, J.; Mir, N. A.; Hasan, T.-u.; Koul, S., Botanical, chemical and pharmacological review of Withania somnifera (Indian ginseng): an ayurvedic medicinal plant. Indian J Drugs Dis 2012, 1, 147-60.
[38] Shah, S.; Saravanan, R.; Gajbhiye, N., Leaf gas exchange, chlorophyll fluorescence, growth and root yield of Ashwagandha (Withania somnifera Dunal.) under soil moisture stress. Indian Journal of Plant Physiology 2010, 15 (2), 117-124.
[39] Singh, P. K.; Sharma, Y. K., Withania somnifera (Ashwagandha): A wonder herb with multiple medicinal properties. Asian Journal of Pharmacy and Pharmacology 2018, 4 (2), 123-130.
[40] Kumar, V.; Dey, A.; Hadimani, M. B.; Emeraldjavascript, M., Chemistry and pharmacology of Withania somnifera: An update. Tang 2015, 5 (1), 1.1-1.13.
[41] Sharada, M.; Ahuja, A.; Suri, K.; Vij, S.; Khajuria, R.; Verma, V.; Kumar, A., Withanolide production by in vitro cultures of Withania somnifera and its association with differentiation. Biologia Plantarum 2007, 51 (1), 161-164.
[42] Nagella, P.; Murthy, H. N., Establishment of cell suspension cultures of Withania somnifera for the production of withanolide A. Bioresource Technology 2010, 101 (17), 6735-6739.
[43] Gupta, P.; Goel, R.; Pathak, S.; Srivastava, A.; Singh, S. P.; Sangwan, R. S.; Asif, M. H.; Trivedi, P. K., De novo assembly, functional annotation and comparative analysis of Withania somnifera leaf and root transcriptomes to identify putative genes involved in the withanolides biosynthesis. PLoS One 2013, 8 (5), e62714.
[44] Dhar, N.; Razdan, S.; Rana, S.; Bhat, W. W.; Vishwakarma, R.; Lattoo, S. K., A decade of molecular understanding of withanolide biosynthesis and in vitro studies in Withania somnifera (L.) Dunal: prospects and perspectives for pathway engineering. Frontiers in plant science 2015, 6, 1031.
[45] Singh, A. K.; Varshney, R.; Sharma, M.; Agarwal, S. S.; Bansal, K. C., Regeneration of plants from alginate-encapsulated shoot tips of Withania somnifera (L.) Dunal, a medicinally important plant species. Journal of plant physiology 2006, 163 (2), 220-223.
[46] Sivamani, S.; Joseph, B.; Kar, B., Anti-inflammatory activity of Withania somnifera leaf extract in stainless steel implant induced inflammation in adult zebrafish. Journal of Genetic Engineering and Biotechnology 2014, 12 (1), 1-6.
[47] Pawar, P.; Gilda, S.; Sharma, S.; Jagtap, S.; Paradkar, A.; Mahadik, K.; Ranjekar, P.; Harsulkar, A., Rectal gel application of Withania somnifera root extract expounds anti-inflammatory and muco-restorative activity in TNBS-induced Inflammatory Bowel Disease. BMC complementary and alternative medicine 2011, 11 (1), 34.
[48] Gupta, A.; Singh, S., Evaluation of anti-inflammatory effect of Withania somnifera root on collagen-induced arthritis in rats. Pharmaceutical biology 2014, 52 (3), 308-320.
[49] Sudhir, S.; Budhiraja, R.; Miglani, G.; Arora, B.; Gupta, L.; Garg, K., Pharmacological studies on leaves of Withania somnifera. Planta medica 1986, 52 (01), 61-63.
[50] Rasool, M.; Varalakshmi, P., Immunomodulatory role of Withania somnifera root powder on experimental induced inflammation: An in vivo and in vitro study. Vascular pharmacology 2006, 44 (6), 406-410.
[51] Gupta, M.; Kaur, G., Withania somnifera as a potential anxiolytic and anti-inflammatory candidate against systemic lipopolysaccharide-induced Neuroinflammation. Neuromolecular medicine 2018, 20 (3), 343-362.
[52] Naidoo, D. B.; Chuturgoon, A. A.; Phulukdaree, A.; Guruprasad, K. P.; Satyamoorthy, K.; Sewram, V., Withania somnifera modulates cancer cachexia associated inflammatory cytokines and cell death in leukaemic THP-1 cells and peripheral blood mononuclear cells (PBMC’s). BMC complementary and alternative medicine 2018, 18 (1), 126.
[53] Manchanda, S.; Kaur, G., Withania somnifera leaf alleviates cognitive dysfunction by enhancing hippocampal plasticity in high fat diet induced obesity model. BMC complementary and alternative medicine 2017, 17 (1), 136.
[54] Hahm, E.-R.; Lee, J.; Kim, S.-H.; Sehrawat, A.; Arlotti, J. A.; Shiva, S. S.; Bhargava, R.; Singh, S. V., Metabolic alterations in mammary cancer prevention by withaferin A in a clinically relevant mouse model. Journal of the National Cancer Institute 2013, 105 (15), 1111-1122.
[55] Winters, M., Ancient medicine, modern use: Withania somnifera and its potential role in integrative oncology. Alternative Medicine Review 2006, 11 (4).
[56] Vyas, A. R.; Singh, S. V., Molecular targets and mechanisms of cancer prevention and treatment by withaferin a, a naturally occurring steroidal lactone. The AAPS journal 2014, 16 (1), 1-10.
[57] Rai, M.; Jogee, P. S.; Agarkar, G.; Santos, C. A. d., Anticancer activities of Withania somnifera: Current research, formulations, and future perspectives. Pharmaceutical biology 2016, 54 (2), 189-197.
[58] Nema, R.; Khare, S.; Jain, P.; Pradhan, A., Anticancer activity of Withania somnifera (leaves) flavonoids compound. Int J Pharm Sci Rev Res 2013, 19 (1), 103-106.
[59] Manoharan, S.; Kaur, J., Anticancer, antiviral, antidiabetic, antifungal and phytochemical constituents of medicinal plants. Am J PharmTech Res 2013, 3, 149-69.
[60] Malik, F.; Kumar, A.; Bhushan, S.; Mondhe, D. M.; Pal, H. C.; Sharma, R.; Khajuria, A.; Singh, S.; Singh, G.; Saxena, A. K., Immune modulation and apoptosis induction: Two sides of antitumoural activity of a standardised herbal formulation of Withania somnifera. European Journal of Cancer 2009, 45 (8), 1494-1509.
[61] Srinivasan, S.; Ranga, R. S.; Burikhanov, R.; Han, S.-S.; Chendil, D., Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells. Cancer research 2007, 67 (1), 246-253.
[62] Sachdeva, H.; Sehgal, R.; Kaur, S., Studies on the protective and immunomodulatory efficacy of Withania somnifera along with cisplatin against experimental visceral leishmaniasis. Parasitology research 2013, 112 (6), 2269-2280.
[63] Davis, L.; Kuttan, G., Immunomodulatory activity of Withania somnifera. Journal of Ethnopharmacology 2000, 71 (1-2), 193-200.
[64] Agarwal, R.; Diwanay, S.; Patki, P.; Patwardhan, B., Studies on immunomodulatory activity of Withania somnifera (Ashwagandha) extracts in experimental immune inflammation. Journal of Ethnopharmacology 1999, 67 (1), 27-35.
[65] Rasool, M.; Varalakshmi, P., Protective effect of Withania somnifera root powder in relation to lipid peroxidation, antioxidant status, glycoproteins and bone collagen on adjuvant‐induced arthritis in rats. Fundamental & clinical pharmacology 2007, 21 (2), 157-164.
[66] Ali, K.; Shuaib, M.; Ilyas, M.; Hussain, F.; Hussain, F., Medicinal uses of chemical extracts from Withania somnifera and its antimicrobial activity: a mini-review. PSM Microbiology 2017, 2 (1), 20-23.
[67] Siddiqui, N. A.; Singh, S.; Siddiquei, M. M.; Khan, T. H., Immunomodulatory effect of Withania somnifera, Asparagus racemosus and Picrorhiza kurroa roots. International Journal of Pharmacology 2012, 8 (2), 108-114.
[68] Zahran, E.; Abd El-Gawad, E. A.; Risha, E., Dietary Withania sominefera root confers protective and immunotherapeutic effects against Aeromonas hydrophila infection in Nile tilapia (Oreochromis niloticus). Fish & shellfish immunology 2018, 80, 641-650.
[69] Jain, S.; Shukla, S. D.; Sharma, K.; Bhatnagar, M., Neuroprotective effects of Withania somnifera Dunn. in hippocampal sub‐regions of female albino rat. Phytotherapy research 2001, 15 (6), 544-548.
[70] Srivastava, A. N.; Ahmad, R.; Khan, M. A., Evaluation and Comparison of the In Vitro Cytotoxic Activity of Withania somnifera Methanolic and Ethanolic Extracts against MDA-MB-231 and Vero Cell Lines. Sci Pharm 2016, 84 (1), 41-59.
[71] Bano, A.; Sharma, N.; Dhaliwal, H. S.; Sharma, V., A systematic and comprehensive review on Withania somnifera (L.) Dunal-an Indian ginseng. Journal of Pharmaceutical Research International 2015, 63-75.
[72] Sankar, S. R.; Manivasagam, T.; Krishnamurti, A.; Ramanathan, M., The neuroprotective effect of Withania somnifera root extract in MPTP-intoxicated mice: an analysis of behavioral and biochemical variables. Cell Mol Biol Lett 2007, 12 (4), 473-81.
[73] Bhatnagar, M.; Sharma, D.; Salvi, M., Neuroprotective effects of Withania somnifera dunal.: A possible mechanism. Neurochem Res 2009, 34 (11), 1975-83.
[74] Kumar, P.; Kumar, A., Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease. J Med Food 2009, 12 (3), 591-600.
[75] Durg, S.; Dhadde, S. B.; Vandal, R.; Shivakumar, B. S.; Charan, C. S., Withania somnifera (Ashwagandha) in neurobehavioural disorders induced by brain oxidative stress in rodents: a systematic review and meta-analysis. J Pharm Pharmacol 2015, 67 (7), 879-99.
[76] Chatterjee, S.; Srivastava, S.; Khalid, A.; Singh, N.; Sangwan, R. S.; Sidhu, O. P.; Roy, R.; Khetrapal, C. L.; Tuli, R., Comprehensive metabolic fingerprinting of Withania somnifera leaf and root extracts. Phytochemistry 2010, 71 (10), 1085-94.
[77] Minhas, U.; Minz, R.; Das, P.; Bhatnagar, A., Therapeutic effect of Withania somnifera on pristane-induced model of SLE. Inflammopharmacology 2012, 20 (4), 195-205.
[78] Prakash, J.; Yadav, S. K.; Chouhan, S.; Singh, S. P., Neuroprotective role of Withania somnifera root extract in maneb-paraquat induced mouse model of parkinsonism. Neurochem Res 2013, 38 (5), 972-80.
[79] Kataria, H.; Wadhwa, R.; Kaul, S. C.; Kaur, G., Water extract from the leaves of Withania somnifera protect RA differentiated C6 and IMR-32 cells against glutamate-induced excitotoxicity. PLoS One 2012, 7 (5), e37080.
[80] Kumar, S.; Harris, R. J.; Seal, C. J.; Okello, E. J., An aqueous extract of Withania somnifera root inhibits amyloid β fibril formation in vitro. Phytotherapy research 2012, 26 (1), 113-117.
[81] Mohanty, I.; Gupta, S. K.; Talwar, K. K.; Dinda, A.; Joshi, S.; Bansal, P.; Saxena, A.; Arya, D. S., Cardioprotection from ischemia and reperfusion injury by Withania somnifera: a hemodynamic, biochemical and histopathological assessment. Molecular and cellular biochemistry 2004, 260 (1), 39-47.
[82] Reuland, D. J.; Khademi, S.; Castle, C. J.; Irwin, D. C.; McCord, J. M.; Miller, B. F.; Hamilton, K. L., Upregulation of phase II enzymes through phytochemical activation of Nrf2 protects cardiomyocytes against oxidant stress. Free Radical Biology and Medicine 2013, 56, 102-111.
[83] Mohanty, I.; Arya, D. S.; Dinda, A.; Talwar, K. K.; Joshi, S.; Gupta, S. K., Mechanisms of cardioprotective effect of Withania somnifera in experimentally induced myocardial infarction. Basic & clinical pharmacology & toxicology 2004, 94 (4), 184-190.
[84] Hina, S.; Rehman, K.; Dogar, Z.-u.-H.; Jahan, N.; Hameed, M.; Khan, Z. I.; Ahmad, K.; Mukhtar, K.; Valeem, E. E., Cardioprotective effect of gemmotherapeutically treated Withania somnifera against chemically induced myocardial injury. Pak J Bot 2010, 42 (2), 1487-1499.
[85] Hamza, A.; Amin, A.; Daoud, S., The protective effect of a purified extract of Withania somnifera against doxorubicin-induced cardiac toxicity in rats. Cell biology and toxicology 2008, 24 (1), 63-73.
[86] Mohanty, I. R.; Arya, D. S.; Gupta, S. K., Withania somnifera provides cardioprotection and attenuates ischemia–reperfusion induced apoptosis. Clinical Nutrition 2008, 27 (4), 635-642.
[87] Gorelick, J.; Rosenberg, R.; Smotrich, A.; Hanuš, L.; Bernstein, N., Hypoglycemic activity of withanolides and elicitated Withania somnifera. Phytochemistry 2015, 116, 283-289.
[88] Andallu, B.; Radhika, B., Hypoglycemic, diuretic and hypocholesterolemic effect of winter cherry (Withania somnifera, Dunal) root. 2000.
[89] Anwer, T.; Sharma, M.; Pillai, K. K.; Iqbal, M., Effect of Withania somnifera on insulin sensitivity in non‐insulin‐dependent diabetes mellitus rats. Basic & clinical pharmacology & toxicology 2008, 102 (6), 498-503.
[90] Udayakumar, R.; Kasthurirengan, S.; Mariashibu, T. S.; Rajesh, M.; Anbazhagan, V. R.; Kim, S. C.; Ganapathi, A.; Choi, C. W., Hypoglycaemic and hypolipidaemic effects of Withania somnifera root and leaf extracts on alloxan-induced diabetic rats. International journal of molecular sciences 2009, 10 (5), 2367-2382.
[91] Anup, K.; Mohan, K.; Suraj, S.; Sandip, F.; Bhushan, F.; Prashant, W., Antimicrobial Activity of Some Important Medicinal Plants of India against Some Plant and Human Pathogens. Research Journal of Pharmacy and Technology 2010, 3 (3), 924-926.
[92] Bisht, P.; Rawat, V., Antibacterial activity of Withania somnifera against Gram-positive isolates from pus samples. Ayu 2014, 35 (3), 330.
[93] Al-Ani, N.; Hadi, S. A.; Nazar, R., Antimicrobial activities of Withania somnifera Crude extract. Sci Agri 2013, 4, 74-76.
[94] Mwitari, P. G.; Ayeka, P. A.; Ondicho, J.; Matu, E. N.; Bii, C. C., Antimicrobial activity and probable mechanisms of action of medicinal plants of Kenya: Withania somnifera, Warbugia ugandensis, Prunus africana and Plectrunthus barbatus. PloS one 2013, 8 (6), e65619.
[95] Owais, M.; Sharad, K.; Shehbaz, A.; Saleemuddin, M., Antibacterial efficacy of Withania somnifera (ashwagandha) an indigenous medicinal plant against experimental murine salmonellosis. Phytomedicine 2005, 12 (3), 229-235.
[96] Singh, N.; Bhalla, M.; de Jager, P.; Gilca, M., An overview on ashwagandha: A Rasayana (Rejuvenator) of Ayurveda. African Journal of Traditional, Complementary and Alternative Medicines 2011, 8 (5S).
[97] Kaur, K.; Rani, G.; Widodo, N.; Nagpal, A.; Taira, K.; Kaul, S.; Wadhwa, R., Evaluation of the anti-proliferative and anti-oxidative activities of leaf extract from in vivo and in vitro raised Ashwagandha. Food and chemical toxicology 2004, 42 (12), 2015-2020.
[98] Mahdi, A. A.; Shukla, K. K.; Ahmad, M. K.; Rajender, S.; Shankhwar, S. N.; Singh, V.; Dalela, D., Withania somnifera improves semen quality in stress-related male fertility. Evidence-Based Complementary and Alternative Medicine 2011, 2011.
[99] Baitharu, I.; Jain, V.; Deep, S. N.; Hota, K. B.; Hota, S. K.; Prasad, D.; Ilavazhagan, G., Withania somnifera root extract ameliorates hypobaric hypoxia induced memory impairment in rats. Journal of ethnopharmacology 2013, 145 (2), 431-441.
##submission.downloads##
प्रकाशित
अंक
खंड
##submission.license##
##submission.copyrightStatement##
##submission.license.cc.by4.footer##This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Authors retain copyright of their work and grant the journal the right of first publication.